Surgery Grand Rounds
April 15, 2015
Duke North – Room 2002
Surgical D & C Case Conference*
6:00 – 7:00 a.m.
Moderator: Steven N. Vaslef, M.D., Ph.D.
*Surgical D & C Conference should be attended by Faculty, Fellows, Residents, and APPs only.
Surgical Grand Rounds
7:00 – 8:00 a.m.
“Cardiothoracic Surgical Trials Network –
5 Years and the Future”
Peter K. Smith, M.D.
Professor of Surgery
Chief, Division of Cardiovascular and Thoracic Surgery
Department of Surgery
Duke University School of Medicine
John H. P. Alexander, M.D., M.H.S.
Professor of Medicine
Vice Chief of Clinical Research
Department of Medicine
Division of Cardiology
Moderator: Allan D. Kirk, M.D., Ph.D., FACS
Presenter Disclosure of Financial Relationships: Drs. Kirk and Vaslef indicate that they do not have any disclosures and has no personal/financial relationships which are relative to this activity. Dr. Smith indicates that he is a Speaker for CSL Behring, but has no personal/financial relationships to disclose which are relative to this activity. Dr. Alexander indicates he is a Principal Investigator for Boehringer Ingelheim, Bristol-Myers Squibb, CSL Behring, Regado Biosciences, Sanofi, Tenex Therapeutics, and Vivus Pharmaceuticals; a Consultant for Bristol-Myers Squibb, Somahlution, and Portola Pharmaceuticals; and a Co-Investigator for National Institutes of Health, but has no personal/financial relationships to disclose which are relative to this activity.
RSS Activity Medical Director(s) Disclosure: Dr. Ranjan Sudan has no personal/financial relationships to disclose which are relative to this activity.
---Global Learning Objectives---
- Review and discuss new advances in general surgery;
- Present and discuss case studies, protocols, treatment guidelines and surgical/pathology report appropriate to General Surgery practice;
- Review and discuss clinical research findings and other evidence from pertinent literature.
The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
---Unapproved Use Disclosure---
Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees: 1) When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (Not FDA approved) ; and 2) Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and /or unsupported opinion. Faculty at this event may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education, and is not intended to promote off-label use of these medications. If you have any questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
The Duke University School Of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in this activity.
In order to receive CME Credit, learners must sign in at the beginning of this event.